Key result
Injection of 1-2 ml of ultrasound contrast medium (Echovist) provided excellent contrast outlining the pericardial space during hemorrhagic pericardiocentesis, with no adverse effects observed.
Why the study?
Does the use of ultrasound contrast medium SH U 454 (Echovist) improve contrast enhancement during pericardiocentesis of hemorrhagic effusions compared to conventional techniques?
Observational
Does the use of ultrasound contrast medium SH U 454 (Echovist) improve contrast enhancement during pericardiocentesis of hemorrhagic effusions compared to conventional techniques?
The use of ultrasound contrast medium SH U 454 (Echovist) provides excellent contrast enhancement to secure correct needle position during pericardiocentesis of hemorrhagic effusions.
Answers are grounded in this paper and cite their sources.
May aid needle positioning in hemorrhagic pericardiocentesis; hypothesis-generating and should not yet change practice.
Although pericardiocentesis is a relatively safe procedure, there are some hazards, particularly when hemorrhagic fluid is aspirated. Having the opportunity to outline the space from which the fluid is withdrawn is of particular interest in this situation. A current technique of echocardiography with contrast enhancement involves injection of a few milliliters of agitated saline solution or reinjection of blood-stained fluid. Performing this procedure, we repeatedly observed a weak and inhomogeneous echo contrast; therefore, we evaluated the applicability of the ultrasound contrast medium SH U 454 (Echovist Schering, Berlin, Germany) for contrast enhancement in hemorrhagic pericardiocentesis. In all patients, pericardiocentesis was performed in a supine position by a subxiphoid approach. A Teflon catheter/needle unit attached to a syringe containing a few milliliters of contrast medium was introduced in the usual way. On the return of hemorrhagic fluid, 1-2 ml of Echovist was injected to provide contrast from the space from which it had been aspirated. We observed excellent contrast clearly outlining the pericardial space through the injection of 1-2 ml of contrast medium. No adverse or side effects were seen resulting from Echovist injection to the pericardial sac. In conclusion, contrast echocardiography appears to be a useful tool to secure the correct position of the needle during pericardiocentesis of hemorrhagic or loculated effusions. It is suggested that injection of Echovist should be considered whenever the contrast obtained by the conventional technique is poor and inconclusive.
No takes yet. Share an insight, caveat, or question.
Watzinger et al. (1998) conducted an observational in Hemorrhagic or loculated pericardial effusions. Ultrasound contrast medium SH U 454 (Echovist) was evaluated on Contrast quality and adverse effects. Injection of 1-2 ml of ultrasound contrast medium (Echovist) provided excellent contrast outlining the pericardial space during hemorrhagic pericardiocentesis, with no adverse effects observed.
Synapse has enriched 10 related papers. Consider them for comparative context: